Search for: "APP Pharmaceuticals, LLC" Results 81 - 100 of 161
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Nov 2010, 12:54 pm by Bexis
Mylan Pharmaceuticals, Inc., 2010 WL 3339274, at *3 (W.D. [read post]
14 Nov 2011, 4:46 pm by FDABlog HPM
Court of Appeals for the Federal Circuit notifying the Court of the enactment of Section 37 and asserting that it resolves the merits of the ongoing ‘404 patent PTE litigation with ANDA sponsor APP Pharmaceuticals, LLC (“APP”). [read post]
1 Feb 2013, 9:42 am by Bexis
Amneal Pharmaceuticals, LLC, 2012 WL 2990697, at *8-9 (E.D. [read post]
18 Jul 2014, 11:55 am
Wyeth Pharmaceuticals, Inc., 2008 WL 7136137 (Ala. [read post]
27 Aug 2012, 9:31 am by Gene Quinn
., and APP Pharmaceuticals, LLC filed abbreviated new drug applications ("ANDAs") seeking approval to manufacture and sell generic versions of Alimta® before the expiration of the '932 patent. [read post]
27 Aug 2012, 9:31 am by Gene Quinn
., and APP Pharmaceuticals, LLC filed abbreviated new drug applications ("ANDAs") seeking approval to manufacture and sell generic versions of Alimta® before the expiration of the '932 patent. [read post]
26 May 2015, 7:42 am
  Claims such as in Mills, which are at loggerheads with FDA criteria for drug development, are precisely those with the most potential for making pharmaceutical manufacturers into “sitting ducks” for litigation, in this instance litigation based on extraneous genetic factors.It may well be that the coming (and to some extent existing) revolution in genetically individualized medical therapy will require changes in how drugs are evaluated, labeled, etc., but this is a… [read post]
31 Oct 2013, 5:00 am
APP Pharmaceuticals, LLC, 2013 WL 5532767 (D. [read post]
24 Jan 2019, 9:30 pm by Bobby Chen
Carrier and Steve Shadowen of Hilliard & Shadowen LLC in a recent article for Antitrust. [read post]